Interleaved Optical Coherence Tomography: Clinical and Laboratory Biomarkers in Patients with Diabetic Macular Edema
(1) Background: The global burden of diabetes mellitus (DM) has been estimated to reach 600 million patients worldwide by 2040. Approximately 200 million people will develop diabetic retinopathy within this time frame. Diabetic macular edema (DME) is a severe, vision-threatening complication that ca...
Main Authors: | Corina-Iuliana Suciu, Vlad-Ioan Suciu, Ancuţa Cuţaş, Simona Delia Nicoară |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/5/765 |
Similar Items
-
Diabetic Macular Edema Optical Coherence Tomography Biomarkers Detected with EfficientNetV2B1 and ConvNeXt
by: Corina Iuliana Suciu, et al.
Published: (2023-12-01) -
Differential diagnosis (occlusion and unocclusal kind) of complicated and diffuse diabetic macular edema with optical coherence tomography method in patients with diabetes type II
by: O. V. Zborovskaya, et al.
Published: (2013-10-01) -
Surgical cystotomy for refractory diabetic cystoid macular edema
by: Tripathy K
Published: (2018-01-01) -
Comparative study between the features of FFA and OCT in diabetic macular edema
by: Qin-Hui Wang, et al.
Published: (2014-12-01) -
Application of optical coherence tomography and optical coherence tomography angiography biomarkers in the prognosis and monitoring of diabetic macular edema
by: Huang Haiyan, et al.
Published: (2024-05-01)